Rapid Nutrition Ready for 618 with KOL Push, Inventory Ramp-Up, and Localized Campaigns
London, United Kingdom – 4 June 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), a leading player in the global HealthTech and wellness space, today announced its readiness for China’s mid-year 618 Shopping Festival, one of the country’s largest e-commerce events. The company has mobilized a focused campaign strategy that leverages key opinion leaders (KOLs), influencers, and significant inventory build-up to capture strong consumer demand and drive visibility across platforms.
“618 is a critical sales moment for us,” said Simon St. Ledger, CEO of Rapid Nutrition. “Our team has worked proactively to position our brand front and center through targeted digital marketing, social amplification, and seamless inventory availability across major channels.”
Key 618 Preparation Highlights:
KOL & Influencer Partnerships: Expanded collaborations with a growing number of KOLs and content creators across Douyin, WeChat, and Xiaohongshu to drive real-time product discovery, livestream engagement, and consumer trust.
Omni-channel Inventory Ramp-Up: Strategic inventory build-up across both online and offline warehouses to support anticipated demand and ensure fast, uninterrupted fulfillment.
Platform Coordination: Deep integration and alignment with key e-commerce platforms for optimal traffic exposure, promotional slotting, and end-to-end customer experience.
Localized Messaging: Tailored campaign content across Douyin and company-owned e-commerce platforms to resonate with Chinese consumer preferences, emphasizing SystemLS’s clean-label ingredients and functional health benefits.
Local Production Support: Increased local manufacturing through Chinese partners to maintain agility and respond quickly to market needs.
As Chinese consumers increasingly gravitate toward trusted, international wellness brands, Rapid Nutrition is confident its comprehensive 618 campaign will drive meaningful engagement, accelerate sell-through of its flagship SystemLS product line, and support its broader 2025 growth targets.
About Rapid Nutrition
Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).